Latest Breaking News On - European hematology association - Page 4 : comparemela.com

Sanofi: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma

Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma FDA Priority Review granted based on positive results from IMROZ phase

United statesFrance generalThomas larsenEvan berlandTimothy gilbertDietmar bergerNicolas obristFelix lauscherTarik elgoutniCorentine driancourtEuropean unionDrug administrationAmerican society of clinical oncologyGlobal head of development at sanofiEuropean hematology associationWorld health organization

Bristol Myers: presents over 130 studies at ASCO

Bristol Myers Squibb is presenting data from more than 130 studies on 25 types of cancer and serious blood disorders at ASCO and EHA.The group has announced the presentation of data from its oncology.

United statesSamit hirawatBristol myers squibbAmerican society of clinical oncologyDrug developmentEuropean hematology associationAmerican societyClinical oncologyBristol myers

Improving success of stem cell transplant in high-risk blood cancers

The new medicine is expected to enable over 99 percent of people from a wide range of racial/ethnic groups to find a donor, research says.

United statesAntonio jimenezEuropean hematology associationAmerican society of clinical oncologyClinical oncology

Sylvester Research Shows New Treatment May Enable More Patients With High-Risk Blood Cancers to Receive Stem Cell Transplants

Sylvester Research Shows New Treatment May Enable More Patients With High-Risk Blood Cancers to Receive Stem Cell Transplants
communitynewspapers.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from communitynewspapers.com Daily Mail and Mail on Sunday newspapers.

United statesMonzr al malkiAntonio jimenezSylvester comprehensive cancer centerEuropean hematology associationUniversity of miami miller school medicineNational marrow donor programCity of hope medical centerAmerican society of clinical oncologyMemorial sloan kettering cancer centerTrinity audioReceive stem cellComprehensive cancer centerMiami miller schoolClinical oncologyNational marrow donor

New stem cell transplant approach may expand donor pool for high-risk blood cancer patients

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

United statesMonzr al malkiAntonio jimenezMemorial sloan kettering cancer centerUniversity of miami miller school medicineAmerican society of clinical oncologySylvester comprehensive cancer centerNational marrow donor programCity of hope medical centerEuropean hematology associationMiami miller schoolAmerican societyClinical oncologyNational marrow donorHope medical center